BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36244092)

  • 1. Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities.
    Sun Q; Huang Z; Yang S; Li Y; Ma Y; Yang F; Zhang Y; Xu F
    Immunobiology; 2022 Nov; 227(6):152287. PubMed ID: 36244092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
    Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
    Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein.
    Srivastava VK; Kaushik S; Bhargava G; Jain A; Saxena J; Jyoti A
    Biomed Res Int; 2021; 2021():7251119. PubMed ID: 34651048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of EpitopeScan, a Python3 toolset for mutation tracking in SARS-CoV-2 immunogenic epitopes.
    Kovalenko A; Viatte S
    Front Immunol; 2024; 15():1356314. PubMed ID: 38840924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis.
    Ozsahin DU; Ameen ZS; Hassan AS; Mubarak AS
    Sci Rep; 2024 Mar; 14(1):6737. PubMed ID: 38509174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies.
    Farriol-Duran R; López-Aladid R; Porta-Pardo E; Torres A; Fernández-Barat L
    Front Immunol; 2023; 14():1278534. PubMed ID: 38124749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mouse CD4
    Bricio-Moreno L; Barreto de Albuquerque J; Neary JM; Nguyen T; Kuhn LF; Yeung Y; Hastie KM; Landeras-Bueno S; Olmedillas E; Hariharan C; Nathan A; Getz MA; Gayton AC; Khatri A; Gaiha GD; Ollmann Saphire E; Luster AD; Moon JJ
    Front Immunol; 2024; 15():1329846. PubMed ID: 38529279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides.
    Ratishvili T; Quach HQ; Haralambieva IH; Suryawanshi YR; Ovsyannikova IG; Kennedy RB; Poland GA
    Vaccine; 2024 Jan; 42(2):162-174. PubMed ID: 38105139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine.
    Wadapurkar R; Singh S; Singh A
    Vaccine; 2024 Mar; 42(7):1630-1647. PubMed ID: 38336561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity.
    Duette G; Lee E; Martins Costa Gomes G; Tungatt K; Doyle C; Stylianou VV; Lee A; Maddocks S; Taylor J; Khanna R; Bull RA; Martinello M; Sandgren KJ; Cunningham AL; Palmer S
    Immunohorizons; 2023 Jun; 7(6):508-527. PubMed ID: 37358499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape and Selection of Vaccine Epitopes in SARS-CoV-2.
    Smith CC; Entwistle S; Willis C; Vensko S; Beck W; Garness J; Sambade M; Routh E; Olsen K; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    bioRxiv; 2020 Jun; ():. PubMed ID: 32577654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.
    Oliveira JR; Ruiz CMR; Machado RRG; Magawa JY; Daher IP; Urbanski AH; Schmitz GJH; Arcuri HA; Ferreira MA; Sasahara GL; de Medeiros GX; Júnior RCVS; Durigon EL; Boscardin SB; Rosa DS; Schechtman D; Nakaya HI; Cunha-Neto E; Gadermaier G; Kalil J; Coelho V; Santos KS
    Front Immunol; 2022; 13():1010105. PubMed ID: 36685521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach.
    Pahlavan Y; Yeganeh O; Asghariazar V; Karami C
    Future Sci OA; 2024; 10(1):FSO939. PubMed ID: 38827807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing novel peptides for detecting the Omicron variant, specifying SARS-CoV-2, and simultaneously screening coronavirus infections.
    Yazdani Z; Rafiei A; Momenizadeh M; Abediankenari S; Yazdani M; Lagzian M
    J Biomol Struct Dyn; 2024 Jun; 42(9):4759-4768. PubMed ID: 37306566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes.
    Ferreira CS; Martins YC; Souza RC; Vasconcelos ATR
    PeerJ; 2021; 9():e12548. PubMed ID: 34909278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS-CoV-2 Through Mutant Bacteriophage Qβ-Receptor Binding Domain Conjugate.
    Tan Z; Yang C; Lin PH; Ramadan S; Yang W; Rashidi Z; Lang S; Shafieichaharberoud F; Gao J; Pan X; Soloff N; Wu X; Bolin S; Pyeon D; Huang X
    Adv Healthc Mater; 2024 May; ():e2302755. PubMed ID: 38733291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource.
    Kim Y; Sette A; Peters B
    J Immunol Methods; 2011 Nov; 374(1-2):62-9. PubMed ID: 21047510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mouse CD4
    Moreno LB; de Albuquerque JB; Neary JM; Nguyen T; Hastie KM; Landeras-Bueno S; Hariharan C; Nathan A; Getz MA; Gayton AC; Khatri A; Gaiha GD; Saphire EO; Luster AD; Moon JJ
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community.
    Koşaloğlu-Yalçın Z; Blazeska N; Carter H; Nielsen M; Cohen E; Kufe D; Conejo-Garcia J; Robbins P; Schoenberger SP; Peters B; Sette A
    Front Immunol; 2021; 12():735609. PubMed ID: 34504503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering.
    Ong E; Huang X; Pearce R; Zhang Y; He Y
    bioRxiv; 2020 Aug; ():. PubMed ID: 32817949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.